Closed-head injury produces a delayed, region-specific defect in glucose-carbon routing at the pyruvate branchpoint in APP/PS1 KI mice
Moallem, E. Z.; Bruntz, R. C.; Cox, M. F.; Bytyqi, L.; Roberts, T. K.; Patel, S. P.; Macheda, T.; Roberts, K. N.; Higgins, E. K.; Sun, R. C.; Gentry, M. S.; Sullivan, P. G.; Johnson, L. A.; Bachstetter, A. D.
Show abstract
Traumatic brain injury (TBI) is a risk factor for Alzheimer's disease (AD), and both conditions are associated with impaired glucose metabolism and mitochondrial dysfunction. We previously reported time-dependent mitochondrial dysfunction following closed-head injury (CHI) in amyloid precursor protein/presenilin 1 (APP/PS1) knock-in (KI) mice, but whether glucose-derived carbon labeling showed a corresponding temporal pattern remained unknown. We hypothesized that early deficits would involve tricarboxylic acid (TCA)-cycle metabolites, whereas chronic changes persisted upstream at the pyruvate-lactate branchpoint. Here, oral uniformly 13C-labeled glucose ([U-13C]-glucose) tracing and gas chromatography-mass spectrometry (GC-MS)-based isotopologue analysis were used to quantify first-turn glucose-derived carbon fate in cortex and hippocampus. To distinguish the effects of age at injury from those of post-injury interval, mice were analyzed 1 month after injury either at 7 or 12 months of age or 8 months after injury at 12 months of age. The most pronounced alterations occurred 8 months after CHI, when KI mice exhibited increased pyruvate and lactate labeling in the cortex and broader increases in glycolytic labeling in the hippocampus. These findings suggest that in APP/PS1 KI mice, chronic closed-head injury produced a delayed shift in glucose-derived carbon labeling centered on glycolytic and pyruvate/lactate nodes, with loss of hippocampal precursor-product coupling but without broad reduction of first-turn TCA-linked labeling.
Matching journals
The top 13 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- APOE4 is Associated with Differential Regional Vulnerability to Bioenergetic Deficits in Aged APOE Mice 94%
- Tauopathy in the APPswe/PS1ΔE9 mouse model of familial Alzheimer’s disease 93%
- Lactate treatment improves brain biochemistry and cognitive function in transgenic Alzheimer's and wild-type mice 93%
Similar papers in this journal
- The therapeutic and diagnostic potential of amyloid β oligomers (AβOs) selective antibodies to treat Alzheimer's disease 92%
- Type-2-diabetes alters CSF but not plasma metabolomic and AD risk profiles in vervet monkeys 92%
- Systematic phenotyping and characterization of the 3xTg-AD mouse model of Alzheimer's Disease 92%
Similar papers in this journal
- Serum metabolome profiling in patients with mild cognitive impairment reveals sex differences in lipid metabolism 94%
- Leptin reduces pathology and increases adult neurogenesis in a transgenic mouse model of Alzheimer’s disease 93%
- Retinal tau phosphorylation in Alzheimer's disease: a mass spectrometry study 93%
Similar papers in this journal
- NMR Analysis of the Correlation of Metabolic Changes in Blood and Cerebrospinal Fluid in Alzheimer Model Male and Female Mice 93%
- Voluntary running does not increase capillary blood flow but promotes neurogenesis and short-term memory in the APP/PS1 mouse model of Alzheimers disease 93%
- Network Biomarkers of Alzheimer's Disease Risk Derived from Joint Volume and Texture Covariance Patterns in Mouse Models 92%